Coherus BioSciences Inc (CHRS) financials · rev $42.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Coherus BioSciences Inc (CHRS) rev $42.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $42.2M | $267.0M |
| Cost of Revenue | $13.8M | $117.6M |
| Gross Profit | $28.4M | $149.4M |
| Operating Income | -$181.1M | -$111.7M |
| Net Income | $168.0M | $28.5M |
| EPS (Diluted) | $1.43 | $0.25 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $258.3M | $448.5M |
| Current Assets | $206.7M | $341.6M |
| Cash & Equivalents | $88.9M | $126.0M |
| Inventory | $3.17M | $70.1M |
| PP&E | $1.34M | $2.84M |
| Total Liabilities | $197.3M | $580.5M |
| Current Liabilities | $140.4M | $283.0M |
| Shareholders' Equity | $61.0M | -$132.0M |
| Retained Earnings | -$1.38B | -$1.55B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$138.5M | -$20.4M |
| Investing Cash Flow | $375.1M | $230.3M |
| Financing Cash Flow | -$273.7M | -$187.0M |
| Net Change in Cash | -$37.1M | $22.9M |
FAQ
What is CHRS P/E and revenue?
Coherus BioSciences Inc (CHRS) rev $42.2M.
What is CHRS revenue?
Coherus BioSciences Inc last cached revenue is $42.2M (FY2025).
Is CHRS profitable?
Coherus BioSciences Inc last cached net income is $168.0M (FY2025).
What are CHRS total assets?
Coherus BioSciences Inc last cached total assets are $258.3M (FY2025).
What is CHRS free cash flow?
No cached cash-flow row for CHRS yet.
Not investment advice. Cached statements, not a live tape.